NasdaqGS - Nasdaq Real Time Price USD

Kestra Medical Technologies, Ltd. (KMTS)

23.09

-1.83

(-7.34%)

At close: May 21 at 4:00:01 PM EDT

Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year® 2025 Mountain West Award Finalist

Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future KIRKLAND, Wash., May 13, 2025 (GLOBE NEWSWIRE) -- Ernst & Young LLP (EY US) announced the finalists for the Entrepreneur Of The Year 2025 Mountain West Award. Now in its 40th year, the Entrepreneur Of The Year program celebrates the bold leaders who disrupt markets through the world’s most ground-breaking companies, revolutionizing industries and making a profound impact on communities. The Mountain West progr

GlobeNewswire 8 days ago

KMTS
-7.34%
Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025

New data highlights strong wear compliance, meaningful arrhythmia detection, and continuity of care in community-based advanced practice provider-driven modelKIRKLAND, Wash., April 29, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, today announced the presentation of new real-world data on the ASSURE® Wearable Cardioverter Defibrillator (WCD) at Heart Rhythm 2025, the annual meeting of the Heart Rhyt

GlobeNewswire 22 days ago

KMTS
-7.34%
Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025

Company to spotlight ASSURE WCD performance and expanded clinical applicationsKIRKLAND, Wash., April 23, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, announced today it will exhibit at Heart Rhythm 2025, the annual meeting of the Heart Rhythm Society (HRS), taking place April 24-27 at the San Diego Convention Center. This marks Kestra’s first major industry showcase following its successful IPO ear

GlobeNewswire 28 days ago

KMTS
-7.34%
Kestra Medical Technologies Reports Third Quarter Fiscal 2025 Financial Results

KIRKLAND, Wash., April 14, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, today reported financial results for the third quarter fiscal 2025, which ended January 31, 2025. Recent Highlights Q3 FY25 revenue and gross margin were in line with the preliminary estimated financial results previously disclosed in the company’s IPO prospectus. Generated revenue of $15.1 million in Q3 FY25, an increase of 82

GlobeNewswire last month

KMTS
-7.34%
Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14

KIRKLAND, Wash., April 02, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced that it will report financial results for the third quarter fiscal 2025 on Monday, April 14. Management will host a corresponding conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. A live and archived webcast of the conference call will be available in the “Events” section of the investor relations website

GlobeNewswire last month

KMTS
-7.34%
Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering

KIRKLAND, Wash., March 14, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, announced today that the underwriters of Kestra’s initial public offering exercised in full their previously disclosed over-allotment option and have purchased 1,782,352 shares of common stock at a public offering price of $17.00 per share. After giving effect to the sale of over-allotment option, the total number of shares sold by Kestra in

GlobeNewswire 2 months ago

KMTS
-7.34%
Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering

KIRKLAND, Wash., March 07, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, announced today the closing of its upsized initial public offering of 11,882,352 common shares at a public offering price of $17.00 per share. The total gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Kestra, were approximately $202 million. All of

GlobeNewswire 2 months ago

KMTS
-7.34%
Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering

KIRKLAND, Wash., March 05, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, today announced the pricing of its upsized initial public offering of 11,882,352 common shares at a public offering price of $17.00 per share. In addition, the underwriters will have a 30-day over-allotment option to purchase up to 1,782,352 additional common shares from Kestra at the initial public offering price, less underwriting discounts

GlobeNewswire 2 months ago

KMTS
-7.34%
Kestra Medical Technologies, Ltd. Announces Launch of Initial Public Offering

KIRKLAND, Wash., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, today announced the launch of its initial public offering of 10,000,000 common shares. In addition, the underwriters will have a 30-day over-allotment option to purchase up to 1,500,000 additional common shares from Kestra at the initial public offering price, less underwriting discounts and commissions. The initial public offering price is ex

GlobeNewswire 2 months ago

KMTS
-7.34%

Performance Overview

Return	KMTS	S&P 500 (^GSPC)
YTD	+0.61%	-0.63%
1-Year	+0.61%	+9.83%
3-Year	+0.61%	+49.81%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Kestra Medical Technologies, Ltd. (KMTS)

Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year® 2025 Mountain West Award Finalist

Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025

Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025

Kestra Medical Technologies Reports Third Quarter Fiscal 2025 Financial Results

Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14

Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering

Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering

Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering

Kestra Medical Technologies, Ltd. Announces Launch of Initial Public Offering

Performance Overview